Cell-cell communication in the tumor microenvironment, carcinogenesis, and anticancer treatment

Cellular Physiology and Biochemistry

Volumn 34, Issue 2, 2014, Pages 213-243

  Brücher, Björn L D M ^a,b,c   Jamall, Ijaz S ^a,b,d  

^a Theodor Billroth Academy   (Germany)

^b International Consortium of Research Excellence   (Germany)

^c Virginia Health System   (United States)

^d Risk Based Decisions Inc   (United States)

Author keywords

Cadherin; Cancer; Carcinogenesis; Cell communication; Connexin; E cadherin; Fibrosis; Gap junction; Inflammation; Integrin; Microenvironment; Mutation; Pannexin; Tight junction; Wound healing

Indexed keywords

ANTINEOPLASTIC AGENT; CADHERIN; GAP JUNCTION PROTEIN; INTEGRIN; ION CHANNEL; MEMBRANE PROTEIN; PANNEXIN; TIGHT JUNCTION PROTEIN; UNCLASSIFIED DRUG; AMINOPTERIN; CHLORMETHINE; CISPLATIN; HORMONE; PLATINUM DERIVATIVE;

ANCHORING JUNCTION; BIOENERGY; CANCER CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER RADIOTHERAPY; CANCER THERAPY; CARCINOGENESIS; CELL COMMUNICATION; CELL JUNCTION; CELL MIGRATION; CELLULAR PARAMETERS; DESMOSOME; HUMAN; MEDICAL RESEARCH; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TIGHT JUNCTION; TUMOR MICROENVIRONMENT; AUTOCRINE EFFECT; CELL ADHESION; ENDOCRINE SYSTEM; EXTRACELLULAR MATRIX; FOCAL ADHESION; GAP JUNCTION; HEMIDESMOSOME; IMMUNOTHERAPY; IONIZING RADIATION; METASTASIS; NEOPLASM; PLASMODESMA; RADIOTHERAPY; SELF CONCEPT; SYNAPTIC TRANSMISSION;

ANTINEOPLASTIC AGENTS; CARCINOGENESIS; CELL COMMUNICATION; HUMANS; TUMOR MICROENVIRONMENT;

EID: 84904270973     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000362978     Document Type: Review

References (273)

1. McCrea PD, Gu D, Balda MS: Junctional music that the nucleus hears: cell-cell contact signaling and the modulation of gene activity. Cold Spring Harb Perspect Biol 2009;1:a002923.
2. Brücher BLDM, Jamall JS: Epistemology of the Origin of Cancer: A New Paradigm. BMC Cancer 2014;14:331.
3. Brücher BLDM, Lyman G, van Hillegersberg R, Pollock RE, Lordick F, Yang HK, Ushijima T, Yeoh KG, Skricka T, Polkowski W, Wallner G, Verwaal V, Garofalo A, D'Ugo D, Roviello F, Steinau HU, Wallace TJ, Daumer M, Maihle N, Reid TJ 3rd, Ducreux M, Kitagawa Y, Knuth A, Zilberstein B, Steele SR, Jamall IS: Imagine a world without cancer. BMC Cancer 2014;14:186.
4. Bauer KH: Mutationstheorie der Geschwulst-Entstehung. Berlin, Julius Springer Verlag, 1928.
5. Hills CE, Kerr MI, Wall MJ, Squires PE: Visfatin reduces gap junction mediated cell-to-cell communication in proximal tubule-derived epithelial cells. Cell Physiol Biochem 2013;32:1200-1212.
6. Epel BL: Plasmodesmata: composition, structure and trafficking. Plant Mol Biol 1994;26:1343-1356.
7. Loewenstein WR, Kanno Y: Studies on an epithelial (gland) cell junction. I. Modifications of surface membrane permeability. J Cell Biol 1964;22:565-586.
8. Weidmann S: The electrical constants of Purkinje fibres. J Physiol 1952;118:348-360.
9. Furshpan EJ, Potter DD: Mechanism of nerve-impulse transmission at a crayfish synapse. Nature 1957;180:342-343.
10. Goodenough DA, Paul DL: Gap junctions. Cold Spring Harb Perspect Biol 2009;1:a0025769.
11. Wiener J, Spiro D, Loewenstein WR: Studies on a epithelial (gland) cell junction. J Cell Biol 1964;22:587-598.
12. Loewenstein WR, Kanno Y, Socolar SJ: Quantum jumps of conductance during formation of membrane channels at cell-cell junction. Nature 1978;274:133-136.
13. Brissette JL, Kumar NM, Gilula NB, Hall JE, Dotto GP: Switch in gap junction protein expression is associated with selective changes in junctional permeability during keratinocyte differentiation. Proc Natl Acad Sci USA 1994;91:6453-6457.
14. Peiris TH, Ovieo NJ: Gap junction proteins: Master regulators of the planarian stem cell response to tissue maintenance and injury. Biochim Biophys Acta 2013;1828:109-117.
15. Furuta K, Lichtenberger R, Helariutta Y: The role of mobile small RNA species during root growth and development. Curr Opin Cell Biol 2012;24:211-216.
16. Stauffer KA, Kumar NM, Gilula NB, Unwin N: Isolation and purification of gap junction channels J Cell Biol 1991;115:141-150.
17. Goodenough DA: The crystalline lens. A system networked by gap junctional intercellular communication. Semin Cell Biol 1992;3:49-58.
18. Kistler J, Evans C, Donaldson P, Bullivant S, Bond J, Eastwood S, Roos M, Dong Y, Gruijters T, Engel A: Ocular lens gap junctions: protein expression, assembly, and structure-function analysis. Microsc Res Tech 1995;31:347-356.
19. Shibata Y, Kumai M, Nishii K, Nakamura K: Diversity and molecular anatomy of gap junctions. Med Electron Microsc 2001;34:153-159.
20. Sosinsky GE: Image analysis of Gap Junction structures. Electron Microsc Rev 1992;5:59-76.
21. Sosinsky GE, Nicholson BJ: Structural organization of gap junction channels. Biochim Biophys Acat 2005;1711:99-125.
22. Guthrie SC, Gilula NB: Gap junctional communication and development. Trends Neurosci 1989;12:12-16.
23. Kumar NM, Gilula NB: Molecular biology and genetics of gap junction channels. Semin Cell Biol 1992;3:3-16.
24. Kumar NM, Gilula NB: The gap junction communication channel. Cell 1996;84:381-388.
25. Larsen WJ, Veenstra RD: Biology of gap junctions. Cell Physiology Source Book. 3rd edition. Academic Press, Elsevier 2001:523-537.
26. Andrysík Z, Procházková J, Kabátková M, Umannová L, Simeková P, Kohoutek J, Kozubík A, Machala M, Vondrá ek J: Aryl hydrocarbon receptor-mediated disruption of contact inhibition is associated with connexin43 downregulation and inhibition of gap junctional intercellular communication. Arch Toxicol 2013;87:491-503.
27. Watanabe Y: Fine structure of bone marrow stroma. Nihon Ketsueki Gakkai Zasshi 1985;48:1688-1700.
28. Umezawa A, Hata J: Expression of gap-junctional protein (connexin 43 or alpha 1 gap junction) is down-regulated at the transcriptional level during adipocyte differentiation of H-1/A marrow stromal cells. Cell Struct Funct 1992;17:177-184.
29. Yeganeh A, Stelmack GL, Fandrich RR, Halayko AJ, Kardami E, Zahradka P: Connexin 43 phosphorylation and degradation are required for adipogenesis. Biochim Biophys Acta 2012;1823:1731-1744.
30. Moore LK, Beyer EC, Burt JM: Characterization of gap junction channels in A7r5 vascular smooth muscle cells. Am J Physiol 1991;260:C975-981.
31. Oviedo-Orta E, Gasque P, Evans WH: Immunoglobulin and cytokine expression in mixed lymphocyte cultures is reduced by disruption of gap junction intercellular communication. FASEB J 2001;15:768-774.
32. Laird DW: Life cycle of connexins in health and disease. Biochem J 2006;394:527-543.
33. Paul DL, Ebhara L, Takemoto LJ, Swenson KI, Goodenough DA: Connexin 46, a novel lens gap junftion protein, induces voltage-gates currents in nonjunctional plasma membrane of Xenopus oocytes. J Cell Biol 1991;115:1077-1088.
34. Harris A, Locke D (eds). Connexins: a guide. New York, Springer, 2009.
35. Sosinsky G: Mixing of connexins in gap junction membrane channels. Proc Natl Acad Sci USA 1995;92:9210-9214.
36. Stauffer KA: The gap junction proteins beta 1-connexin (connexin-32) and beta 2-connexin (connexin-26) can form heteromeric hemichannels. J Biol Chem 1995;270:6768-6772.
37. Jiang JX, Goodenough DA: Heteromeric connexons in lens gap junction channels. Proc Natl Acad Sci USA 1996;93:1287-1291.
38. Fallon RF, Goodenough DA: Five-hour half-life of mouse liver gap-junction protein. J Cell Biol 1981;90:521-526.
39. Musil LS, Goodenough DA: Biochemical analysis of connexin43 intracellular transport, phosphorylation, and assembly into gap junctional plaques. J Cell Biol 1991;115:1357-1374.
40. Laird DW, Puranam KL, Revel JP: Turnover and phosphorylation dynamics of connexin43 gap junction protein in cultured cardiac myocytes. Biochem J 1991;273:67-72.
41. Krutovskikh V, Mazzoleni G, Mironov N, Omori Y, Aguelon AM, Mesnil M, Berger F, Partensky C, Yamasaki H: Altered homologous and heterologous gap-junctional intercellular communication in primary human liver tumors associated with aberrant protein localization but not gene mutation of connexin 32. Int J Cancer 1994;56:87-94.
42. Lang F, Föller M, Lang KS, Lang PA, Ritter M, Gulbins E, Vereninov A, Huber SM: Ion channels in cell proliferation and apoptotic cell death. J Membr Biol 2005;205:147-157.
43. Hille B: Ionic channels in excitable membranes. Current problems and biophysical approaches. Biophys J 1978;22:283-294.
44. Hodgkin AL, Huxley A F: Action Potentials Recorded from Inside a Nerve Fibre. Nature 1939;144:710.
45. Huxley AF, Niedergerke R: Structural changes in muscle during contraction; interference microscopy of living muscle fibres. Nature 1954;173:971-973.
46. Huxley H, Hanson J: Changes in the cross-striations of muscle during contraction and stretch and their structural interpretation". Nature 1954;173:973-976.
47. Neher E, Sakmann B, Steinbach JH: The extracellular patch clamp: a method for resolving currents through individual open channels in biological membranes. Pflugers Archiv 1978;375:219-228
48. Lang F, Abed M, Lang E, Föller M: Oxidative stress and suicidal erythrocyte death. Antioxid Redox Signal 2014;21:138-153.
49. Yen MR, Saier MH Jr: Gap junctional proteins of animals the innexin/ pannexin superfamily. Prog Biophys Mol Biol 2007;94:5-14.
50. Sosinsky GE, Boassa D, Dermietzel R, Duffy HS, Laird DW, MacVicar B, Naus CC, Penuela S, Scemes E, Spray DC, Thompson RJ, Zhao HB, Dahl G: Pannexin channels are not gap junction hemichannels. Channels (Austin) 2011;5:193-197.
51. Ambrosi C, Gassmann O, Pranskevich JN, Boassa D, Smock A, Wang J, Dahl G, Steinem C, Sosinksy GE: Pannexin1 and Pannexin2 channels show quaternary similarities to connexins and different oligomerization numbers from each other. J Biol Chem 2010;285:24420-24431.
52. Boassa D, Ambrosi C, Qiu F, Dahl G, Gaietta G, Sosinsky G: Pannexin1 channels contain a glycosylation site that targets the hexamer to the plasma membrane. J Biol Chem 2007;282:31733-31743.
53. Pelegrin P, Surprenant A: Pannexin-1 mediates large pore formation and interleukin-1 release by the ATP-gated P2X7 receptor. EMBO J 2006;25:5071-5082.
54. Scanziani E, Grassi F: Purinergic controlof T cell activation by ATP released through pannexin-1 hemichannels. Sci Signal 2008;1:ra6.
55. Locovei S, Bao L, Dahl G: Pannexin 1 in erythrocytes: Function without a gap. Proc Natl Acad Sci USA 2006;103:7655-7659.
56. Wong CW, Christen T, Roth I, Chadjichristos CE, Derouette JP, Foglia BF, Chanson M, Goodenough DA, Kwak BR: Connexin37 protects against atherosclerosis by regulating monocyte adhesion. Nat Med 2006;12:950-954.
57. Farquahar MG, Palade GE: Junctional complexes in various epithelia. J Cell Biol 1963; 17:375-412.
58. Chalcroft JP, Bullivant S: An interpretation of liver cell membrane and junction structure based on observation of freeze-fracture replicas of both sides of the fracture. J Cell Biol 1970;47:49-60.
59. González-Mariscal L, Betanzos A, Nava P, Jaramillo BE: Tight junction proteins. Prog Biophys Mol Biol 2003;81:1-44.
60. Citi S, Cordenonsi M: Tight junction proteins. Biochim Biophys Acta 1998;1448:1-11.
61. Stevenson BR, Siliciano JD, Mooseker MS, Goodenough DA: Identification of ZO-1: a high molecular weight polypeptide associated with the tight junction (zonula occludens) in a variety of epithelia. J Cell Biol1986;103:755-766.
62. González-Mariscal L, Tapia R, Chamorro D: Crosstalk of tight junction components with signaling pathways. Biochim Biophys Acta 2008;1778:729-756.
63. Bizzozero G: Le opere scientifi che di Giulio Bizzozero. Introduzione del Prof. Camillo Golgi, 2 vols. Milano: U. Hoepli. 1905.
64. Schaffer J: Vorlesungen über Histologie und Histogenese. Leipzig, W. Engelmann, 1920.
65. Harmon RM, Green KJ: Structural and functional diversity of desmosomes. Cell Commun Adhes 2013;20:171-187.
66. Halbleib JM, Nelson WJ: Cadherins in development: cell adhesion, sorting, and tissue morphogenesis. Genes Dev 2006;20:3199-3214.
67. Yap AS: The morphogenetic role of cadherin cell adhesion molecules in human cancer: a thematic review. Cancer Invest 1998;16:252-261.
68. Kurrle N, Völlner F, Eming R, Hertl M, Banning A, Tikkanen R: Flotillins Directly Interact with Catenin and Regulate Epithelial Cell-Cell Adhesion. PLoS One 2013;8:e84393.
69. Jamora C, Fuchs E: Intercellular adhesion, signaling and the cytoskeleton. Nat Cell Biol 2002;4:E101-108.
70. Müller EJ , Williamson L , Kolly C , Suter MM: Outside in signaling through integrins and cadherins: a central mechanism to control epidermal growth and differentiation? J Invest Dermatol 2008;128:501-516.
71. Gloushankova NA: Changes in regulation of cell-cell adhesion during tumor transformation. Biochemistry (Mosc) 2008;73:742-750.
72. Meng W, Takeichi M: Adherens junction: molecular architecture and regulation. Cold Spring Harb Perspect Biol 2009;1:a002899.
73. Oda H, Takeichi M: Evolution: structural and functional diversity of cadherin at the adherens junction. J Cell Biol 2011;193:1137-1146.
74. Hu G: p120-Cateinn: a novel regulator of innate immunity and inflammation. Crit Rev Immunol 2012;32:127-138.
75. Legan PK, Collins JE, Garrod DR: The molecular biology of desmosomes and hemidesmosomes: "what's in the name"? Bioessays 1992;14:385-393.
76. Jamora C, DasGupta R, Kocieniewski P, Fuchs E: Links between signal transduction, transcrioption and adhesion in epithelial bud development. Nature 2003;422:317-322.
77. van Norman JM, Breakfield NW, Benfey PN: Intercellular communication during plant development. Plant Cell 2011;23:855-864.
78. Horwitz A, Duggan K, Greggs R, Decker C, Buck C: The cell substrate attachment (CSAT) antigen has properties of a receptor for laminin and fibronectin. J Cell Biol 1986;101:2134-2144.
79. Hynes RO: Integrins: bidirectional, allosteric signaling machines. Cell 2002;110:673-687.
80. Wolfenson H, Lavelin I, Geiger B: Dynamic regulation of the structure and functions of integrin adhesions. Dev Cell 2013;24:447-458.
81. Nermut MV, Green NM, Eason P, Yamada SS, Yamada KM: Electron microscopy and structural model of human fibronectin receptor. EMBO J 1988;7:4093-4099.
82. Humphries MJ: Integrin structure. Biochem Soc Trans 2000;28:311-339.
83. Marelli UK, Rechenmacher F, Sobahi TR, Mas-Moruno C, Kessler H: Tumor Targeting via Integrin Ligands. Front Oncol 2013;3:222.
84. Suh HN, Han HJ: Fibronectin-induced VEGF receptor and calcium channel transactivation stimulate GLUT-1 synthesis and trafficking through PPAR and TC10 in mouse embryonic stem cells. Stem Cell Res 2013;10:371-386.
85. Borradori L, Sonnenberg A: Structure and function of hemidesmosomes: more than simpe adhesion complexes. J Investigative Dermatology 1999;112:411-418.
86. Stanley JR, Hawley-Nelson P, Yuspa SH, Shevach EM, Katz SI: Characterization of bullous pemphigoid antigen: a unique basement membrane protein of stratified squamous epithelia. Cell 1981;24:897-903.
87. Green KJ, Jones JC: Desmosomes and hemidesmosomes: structure and function of molecular components. FASEB J 1996;10:871-881.
88. Stepp MA, Spurr-Michaud S, Gibson IK: Integrins in the wound and unwounded stratified squamous epithelium of the cornea. Invest Ophtalmol Vis Sci 1993;34:1829-1844.
89. Rezniczek GA, de Pereda JM, Reipert S, Wiche G: Linking integrin alpha6beta4-based cell adhesion to the intermediate filament cytoskeleton: direct interaction between the beta4 subunit and plectin at multiple molecular sites. J Cell Biol 1998;141:209-225.
90. Ozawa T, T, Tsuruta D, Jones JC, Ishii M, Ikeda K, Harada T, Aoyama Y, Kawada A, Kobayashi H: Dynamic relationship of focal contacts and hemidesmosome protein complexes in live cells. J Invest Dermatol 2010;130:1624-35
91. Madigan MC, Holden BA: Reduced epithelial adhesion after extended contact lens wear correlates with reduced hemidesmosome density in cat cornea. Invest Ophthalmol Vis Sci 1992;33:314-323.
92. Chi C, Trinkaus-Randall V: New insights in wound response and repair of epithelium. J Cell Physiol 2013;228:925-929.
93. Dowling J, Yu Q-C, Fuchs E: 4 integrin is required for hemidesmosome formation, cell adhesion and cell survival. J Cell Biol 1996;134:559-572.
94. Chiarugi P: Reactive oxygen species as mediators of cell adhesion. Ital J Biochem 2003;52:28-32.
95. Sawhney RS, Liu W, Brattain MG: A novel role of ERK5 in integrin-mediated cell adhesion and motility in cancer cells via FAK signaling. J Cell Physiol 2009;219:152-160.
96. Yousif NG: Fibronectin promotes migration and invasion of ovarian cancer cells through up-regulation of FAK-PI3K/Akt pathway. Cell Biol Int 2014;38:85-91.
97. Wang P, Han L, Shen H, Wang P, Lv C, Zhao G, Niu J, Xue L, Wang QJ, Tong T, Chen J: Protein kinase D1 is essential for Ras-induced senescence and tumor suppression by regulating senescence-associated inflammation. Proc Natl Acad Sci USA 2014;111:7683-7688.
98. Guterres FA, Martinez GR, Rocha ME, Winnischofer SM: Simvastatin rises reactive oxygen species levels and induces senescence in human melanoma cells by activation of p53/p21 pathway. Exp Cell Res 2013;319:2977-1988.
99. Knösel T, Altendorf-Hofmann A, Lindner L, Issels R, Hermeking H, Schuebbe G, Gibis S, Siemens H, Kampmann E, Kirchner T: Loss of p16(INK4a) is associated with reduced patient survival in soft tissue tumours, and indicates a senescence barrier. J Clin Pathol 2014;67:592-598.
100. Taniguchi Ishikawa E, Gonzalez-Nieto D, Ghiaur G, Dunn SK, Ficker AM, Murali B, Madhu M, Gutstein DE, Fishman GI, Barrio LC, Cancelas JA: Connexin-43 prevents hematopoietic stem cell senescence through transfer of reactive oxygen species to bone marrow stromal cells. Proc Natl Acad Sci USA 2012;109:9071-9076.
101. Ben-Jacob E, Levine H: Self-engineering capabilities in bacteria. J R Soc Interface 2006;3:197-214.
102. Taga ME, Bassler BL: Chemical communication among bacteria. Proc Natl Acad Sci USA 2003;100:14549-14554.
103. Farghaly AH: Factors influencing the growth and light production of luminous bacteria. J Cell Comp Physiol 1950;36:165-184.
104. Hastings JW, Greenberg EP: Quorum sensing: the explanation of a curious phenomenon reveals a common characteristic of bacteria. J Bacteriol 1999;181:2667-2668.
105. Fuqua WC, Winans SC, Greenberg EP: Quorum sensing in bacteria: the LuxR-LuxI family of cell density-responsive transcriptional regulators. J Bacteriol 1994;176:269-275.
106. Anderson WAD (ed). Pathology, Volume One, 6th edition, St. Louis, The CV Mosby Company, 1971.
107. Rosenfeld S: Are the somatic mutation and tissue organization field theories of carcinogenesis incompatible? Cancer Inform 2013;12:221-229.
108. Matveev V: What is your opinion on this paper? Researchgate 2014: https://www.researchgate.net/post/ What-is-your-opinion-on-this-paper.
109. Krawczyk M, Emerson BM: p50-associated COX-2 extragenic RNA (PACER) activates COX-2 gene expression by occluding repressive NF-κB complexes. Elife 2014;3:e01776.
110. Porter KR, Kallman FL: Significance of cell particulates as seen by electron microscopy. Ann N Y Acad Sci 1952;54:882-891.
111. Porter KR: Observations on a submicroscopic basophilic component of cytoplasm. J Exp Med 1953;97:727-750.
112. Fawcett DW: The membranes of the cytoplasm. Lab Invest 1961;10:1162-1188.
113. Halemano K, Guo K, Heilman KJ, Barrett BS, Smith DS, Hasenkrug KJ, Santiago ML: Immunoglobulin somatic hypermutation by APOBEC3/Rfv3 during retroviral infection. Proc Natl Acad Sci USA 2014;111:7759-7764.
114. Onozawa M, Zhang Z, Kim YJ, Goldberg L, Varga T, Bergsagel PL, Kuehl WM, Aplan PD: Repair of DNA double-strand breaks by templated nucleotide sequence insertions derived from distant regions of the genome. Proc Natl Acad Sci USA 2014;111:7729-7734.
115. WangY, Mehta PP: Facilitation of gap-junctional communication and gap-junction formation in mammalian cells by inhibition of glycosylation. Eur J Cell Biol 1995;67:285-296.
116. Garber SA, Fernstrom MJ, Stoner GD, Ruch RJ: Altered gap junctional intercellular communication in neoplastic rat esophageal epithelial cells. Carcinogenesis 1997;18:1149-1153.
117. Figueroa XF, Duling BR: Gap junctions in the control of vascular function. Antioxid Redox Signal 2009;11:251-266.
118. Qazi H, Palomino R, Shi ZD, Munn LL, Tarbell JM: Cancer cell glycocalyx mediates mechanotransduction and flow-regulated invasion. Integr Biol (Camb) 2013;5(11):1334-1343.
119. Hunter J: A treatise on the blood, inflammation and gunshot wounds. London: Nichol G, P 531, 1794.
120. Oort J, Scheper RJ: Histopathology of acute and chronic inflammation. Agents Actions Suppl 1977;3:25-30.
121. Coffelt SB, de Visser KE: Cancer: Inflammation lights the way to metastasis. Nature 2014;507:48-49.
122. Vliagoftis H, Hutson AM, Mahmudi-Azer S, Kim H, Rumsaeng V, Oh CK, Moqbel R, Metcalfe DD: Mast cells express connexins on their cytoplasmic membrane. J Allergy Clin Immunol 1999;103:656-662.
123. Eugenin EA, Branes MC, Berman JW, Saez JC: TNF-alpha plus IFN-gamma induce connexin43 expression and formation of gap junctions between human monocytes/macrophages that enhance physiological responses. J Immunol 2003;170:1320-1328.
124. Jara PI, Boric MP, Saez JC: Leukocytes express connexin 43 after activation with lipopolysaccharide and appear to form gap junctions with endothelial cells after ischemia-reperfusion. Proc Natl Acad Sci USA 1995;92:7011-7015.
125. Xia Y, Jin X, Yan J, Entman ML, Wang Y: CXCR6 Plays a Critical Role in Angiotensin II-Induced Renal Injury and Fibrosis. Arterioscler Thromb Vasc Biol 2014.May 22.[Epub ahead of print].
126. Oliveira AM, Ross JS, Fletcher JA: Tumor suppressor genes in breast cancer: the gatekeepers and the caretakers. Am J Clin Pathol 2005;124:S16-28.
127. Chetram MA, Don-Salu-Hewage AS, Hinton CV: ROS enhances CXCR4-mediated functions through inactivation of PTEN in prostate cancer cells. Biochem Biophys Res Commun 2011;410:195-200.
128. Gingery A1, Bradley EW, Pederson L, Ruan M, Horwood NJ, Oursler MJ: TGF-beta coordinately activates TAK1/MEK/AKT/NFkB and SMAD pathways to promote osteoclast survival. Exp Cell Res 2008;314:2725-2738.
129. Matsuura I, Denissova NG, Wang G, He D, Long J, Liu F: Cyclin-dependent kinases regulate the antiproliferative function of Smads. Nature 2004;430:226-231.
130. Dai C, Yang J, Liu Y: Transforming growth factor-beta1 potentiates renal tubular epithelial cell death by a mechanism independent of Smad signaling. J Biol Chem 2003;278:12537-12545.
131. Edlund S, Bu S, Schuster N, Aspenström P, Heuchel R, Heldin NE, ten Dijke P, Heldin CH, Landström M: Transforming growth factor-beta1 (TGF-beta)-induced apoptosis of prostate cancer cells involves Smad7- dependent activation of p38 by TGF-beta-activated kinase 1 and mitogen-activated protein kinase kinase 3. Mol Biol Cell 2003;14:529-544.
132. Yoo J, Ghiassi M, Jirmanova L, Balliet AG, Hoffman B, Fornace AJ Jr, Liebermann DA, Bottinger EP, Roberts AB: Transforming growth factor-beta-induced apoptosis is mediated by Smad-dependent expression of GADD45b through p38 activation. J Biol Chem 2003;278:43001-43007.
133. Kim KY, Kim BC, Xu Z, Kim SJ: Mixed lineage kinase 3 (MLK3)-activated p38 MAP kinase mediates transforming growth factor-beta-induced apoptosis in hepatoma cells. J Biol Chem 2004;279:29478-29484.
134. Landström M, Heldin NE, Bu S, Hermansson A, Itoh S, ten Dijke P, Heldin CH: Smad7 mediates apoptosis induced by transforming growth factor beta in prostatic carcinoma cells. Curr Biol 2000;10:535-538.
135. Mazars A, Lallemand F, Prunier C, Marais J, Ferrand N, Pessah M, Cherqui G, Atfi A: Evidence for a role of the JNK cascade in Smad7-mediated apoptosis. J Biol Chem 2001;276:36797-36803.
136. Townsend DM, Tew KD: The role of glutathione-S-transferase in anti-cancer drug resistance. Oncogene 2003;22:7369-7375.
137. Cullen KJ, Newkirk KA, Schumaker LM, Aldosari N, Rone JD, Haddad BR: Glutathione S-transferase pi amplification is associated with cisplatin resistance in head and neck squamous cell carcinoma cell lines and primary tumors. Cancer Res 2003;63:8097-8102.
138. Twu O, Dessí D, Vu A, Mercer F, Stevens GC, de Miguel N, Rappelli P, Cocco AR, Clubb RT, Fiori PL, Johnson PJ: Trichomonas vaginalis homolog of macrophage migration inhibitory factor induces prostate cell growth, invasiveness, and inflammatory responses. Proc Natl Acad Sci USA 2014;111:8179-8184.
139. Henderson NC, Arnold TD, Katamura Y, Giacomini MM, Rodriguez JD, McCarty JH, Pellicoro A, Raschperger E, Betsholtz C, Ruminski PG, Griggs DW, Prinsen MJ, Maher JJ, Iredale JP, Lacy-Hulbert A, Adams RH, Sheppard D: Targeting of v integrin identifies a core molecular pathway that regulates fibrosis in several organs. Nat Med 2013;19:1617-1624.
140. Chen J, Xia Y, Lin X, Feng XH, Wang Y: Smad3 signaling activates bone marrow-derived fibroblasts in renal fibrosis. Lab Invest 2014;94:545-556.
141. Shen X, Hu PP, Liberati NT, Datto MB, Frederick JP, Wang XF: TGF-beta-induced phosphorylation of Smad3 regulates its interaction with coactivator p300/CREB-binding protein. Mol Biol Cell 1998;9:3309-3319.
142. Wang G, Matsuura I, He D, Liu F: Transforming growth factor-{beta}- inducible phosphorylation of Smad3. J Biol Chem 2009;284:9663-9673.
143. Lu GX, Bian DF, Ji Y, Guo JM, Wei ZF, Jiang SD, Xia YF, Dai Y: Madecassoside Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Mice by Downregulating Collagen Deposition. Phytother Res doi: 10.1002/ptr.5120.
144. Ding N, Yu RT, Subramaniam N, Sherman MH, Wilson C, Rao R, Leblanc M, Coulter S, He M, Scott C, Lau SL, Atkins AR, Barish GD, Gunton JE, Liddle C, Downes M, Evans RM: A vitamin D receptor/SMAD genomic circuit gates hepatic fibrotic response. Cell 2013;153:601-613.
145. Friedman SL, Roll FJ, Boyles J, Bissell DM: Hepatic lipocytes: the principal collagen-producing cells of normal rat liver. Proc Natl Acad Sci USA 1985;82:8681-8685.
146. Yokoi Y, Namihisa T, Kuroda H, Komatsu I, Miyazaki A, Watanabe S, Usui K: Immunocytochemical detection of desmin in fat-storing cells (Ito cells). Hepatology 1984;4:709-714.
147. Mayne R, Vail MS, Miller EJ: Characterization of the collagen chains synthesized by cultured smooth muscle cells derived from rhesus monkey thoracic aorta. Biochemistry 1978;17:446-452.
148. Lazarides E: Intermediated filaments as mechanical integrators of cellular space. Nature 1980;283:249-256.
149. Winau F, Hegasy G, Weiskirchen R, Weber S, Cassan C, Sieling PA, Modlin RL, Liblau RS, Gressner AM, Kaufmann SH: Ito cells are liver-resident antigen-presenting cells for activating T cell responses. Immunity 2007;26:117-129.
150. Vivier E, Raulet DH, Moretta A, Caligiuri MA, Zitvogel L, Lanier LL, Yokoyama WM, Ugolini S: Innate or adaptive immunity? The example of natural killer cells. Science 2011;331:44-49.
151. Scheper W, Gründer C, Straetemans T, Sebestyen Z, Kuball J: Hunting for clinical translation with innate-like immune cells and their receptors. Leukemia 2014;28:1181-1190.
152. Parham P: MHC class I molecules and KIRs in human history, health and survival. Nat Rev Immunol 2005;5:201-214.
153. Tittarelli A, Mendoza-Naranjo A, Farías M, Guerrero I, Ihara F, Wennerberg E, Riquelme S, Gleisner A, Kalergis A, Lundqvist A, López MN, Chambers BJ, Salazar-Onfray F: Gap junction intercellular communications regulate NK cell activation and modulate NK cytotoxic capacity. J Immunol 2014;192:1313-1319.
154. Henderson NC, Sheppard D: Integrin-mediated regulation of TGFbeta in fibrosis. Biochim Biophys Acta 2013;1832:891-896.
155. Fausther M, Lavoie EG, Dranoff JA: Contribution of Myofibroblasts of Different Origins to Liver Fibrosis. Curr Pathobiol Rep 2013;1:225-230.
156. Harms JF, Welch DR, Samant RS, Shevde LA, Miele ME, Babu GR, Goldberg SF, Gilman VR, Sosnowski DM, Campo DA, Gay CV, Budgeon LR, Mercer R, Jewell J, Mastro AM, Donahue HJ, Erin N, Debies MT, Meehan WJ, Jones AL, Mbalaviele G, Nickols A, Christensen ND, Melly R, Beck LN, Kent J, Rader RK, Kotyk JJ, Pagel MD, Westlin WF, Griggs DW: A small molecule antagonist of the alpha(v)beta3 integrin suppresses MDA-MB-435 skeletal metastasis. Clin Exp Metastasis 2004;21:119-128.
157. Deng YR, Yoshida K, Jin QL, Murata M, Yamaguchi T, Tsuneyama K, Moritoki Y, Niu JQ, Matsuzaki K, Lian ZX: Reversible phospho-Smad3 signaling between tumour suppression and fibrocarcinogenesis in chronic hepatitis B infection. Clin Exp Immunol 2014;176:102-111.
158. De Minicis S, Rychlicki C, Agostinelli L, Saccomanno S, Candelaresi C, Trozzi L, Mingarelli E, Facinelli B, Magi G, Palmieri C, Marzioni M, Benedetti A, Svegliati-Baroni G: Dysbiosis contributes to fibrogenesis in the course of chronic liver injury in mice. Hepatology 2014;59:1738-1749.
159. Yang L, Kwon J, Popov Y, Gajdos GB, Ordog T, Brekken RA, Mukhopadhyay D, Schuppan D, Bi Y, Simonetto D, Shah VH: Vascular endothelial growth factor promotes fibrosis resolution and repair in mice. Gastroenterology 2014;146:1339-1350.e1.
160. Shattil SJ, Kim C, Ginsberg MH: The final steps of integrin activation: the end game. Nat Rev Mol Cell Biol 2010;11:288-300.
161. Box C, Rogers SJ, Mendiola M, Eccles SA: Tumour-microenvironmental interactions: paths to progression and targets for treatment. Semin Cancer Biol 2010;20:128-138.
162. Yu Y, Shi X, Shu Z, Xie T, Huang K, Wei L, Song H, Zhang W, Xue X: Stromal Cell-Derived Factor-1 (SDF-1)/ CXCR4 Axis Enhances Cellular Invasion in Ovarian Carcinoma Cells Via Integrin β1 and β3 Expressions. Oncol Res 2014;21:217-225.
163. Wang B, Wang W, Niu W, Liu E, Liu X, Wang J, Peng C, Liu S, Xu L, Wang L, Niu J: SDF-1/CXCR4 axis promotes directional migration of colorectal cancer cells through upregulation of integrin v-6. Carcinogenesis 2014;35:282-291.
164. Sun X, Cheng G, Hao M, Zheng J, Zhou X, Zhang J, Taichman RS, Pienta KJ, Wang J: CXCL12/CXCR4/CXCR7 Chemokine Axis and Cancer Progression. Cancer Metastasis Rev 2010;29:709-722.
165. Madsen CD, Sahai E: Cancer Dissemination - Lessens from Leukocytes. Dev Cell 2010;19:13-26.
166. Moharita AL, Taborga M, Corcoran KE, Bryan M, Patel PS, Rameshwar P: SDF-1alpha regulation in breast cancer cells contacting bone marrow stroma is critical for normal hematopoiesis. Blood 2006;108:3245-3252.
167. Pritchett J, Wright C, Zeef L, Nadarajah B: Stromal derived factor-1 exerts differential regulation on distinct cortical cell populations in vitro. BMC Dev Biol 2007;7:31.
168. Cavanagh JF, Mione MC, Pappas IS, Parnavelas JG: Basic fibroblast growth factor prolongs the proliferation of rat cortical progenitor cells in vitro without altering their cell cycle parameters. Cereb Cortex 1997;7:293-302.
169. Yi T, Zhai B, Yu Y, Kiyotsugu Y, Raschle T, Etzkorn M, Seo HC, Nagiec M, Luna RE, Reinherz EL, Blenis J, Gygi SP, Wagner G: Quantitative phosphoproteomic analysis reveals system-wide signaling pathways downstream of SDF-1/CXCR4 in breast cancer stem cells. Proc Natl Acad Sci USA 2014;111:E2182-2190.
170. Wolf J, Dewi DL, Fredebohm J, Müller-Decker K, Flechtenmacher C, Hoheisel JD, Boettcher M: A mammosphere formation RNAi screen reveals that ATG4A promotes a breast cancer stem-like phenotype. Breast Cancer Res 2013;15:R109.
171. Cox TT, Bird D, Baker AM, Barker HE, Ho MW, Lang G, Erler JT: LOX-mediated collagen crosslinking is responsible for fibrosis-enhanced metastasis. Cancer Res 2013;73:1721-1732
172. Manov I, Hirsh M, Iancu TC, Malik A, Sotnichenko N, Band M, Avivi A, Shams I: Pronounced cancer resistance in a subterranean rodent, the blind mole-rat, Spalax: in vivo and in vitro evidence. BMC Biology 2013;11:91.
173. Tian X, Azpurua J, Hine C, Vaidya A, Myakishev-Rempel M, Ablaeva J, Mao Z, Nevo E, Gorbunova V, Seluanov A: High-molecular-mass hyaluronan mediates the cancer resistance of the naked mole rat. Nature 2013;499:346-349.
174. Minami K, Miyawaki K, Hara M, Yamada S, Seino S: Tracing phenotypic reversibility of pancreatic cells in vitro. J Diabetes Investig 2010;1:242-251.
175. Zeng Y, Tarbell JM: The adaptive remodeling of endothelial glycocalyx in response to fluid shear stress. PLoS One 2014;9:e86249
176. Slavkin HC, Greulich RC (eds): Extracellular Matrix Influences on Gene Expression. Academic Press, Inc, New York Academic 1975, P833.
177. Mecham RP, Madaras JG, Senior RM: Extracellular matrix-specific induction of elastogenic differentiation and maintenance of phenotypic stability in bovine ligament fibroblasts. J Cell Biol 1984;98:1804-1812.
178. Zhe X, Cher ML, Bonfil RD: Circulating tumor cells: finding the needle in the haystack. Am J Cancer Res 2011;1:740-751.
179. Fidler JJ: Metastasis: guantitative analysis of distribution and fate of tumor embolilabeled with 125 I-5- iodo-2'-deoxyuridine. J Natl Cancer Inst 1970;45:773-782.
180. Stoka AM: Phylogeny and evolution of chemical communication: an endocrine approach. J Mol Endoccrinol 1999;22:207-225.
181. Bonner JT, Sieja TW, Hall EM: Further evidence for the sorting out of cells in the differentiation of the cellular slime mold Dictyostelium. J Embryol Exp Morphol 1971;25:457-465.
182. Vallesi A, Giuli G, Bradshaw RA, Luporini P: Autocrine mitogenic activity of pheromones produced by the protozanciliate Euplotes raikovi. Nature 1995;376:522-524.
183. Coutinho P, Qiu C, Frank S, Tamber K, Becker D: Dynamic changes in connexin expression correlate with key events in the wound healing process. Cell Biol Int 2003;27:525-541.
184. Scemes E , Spray DC, Meda P: Connexins, pannexins, innexins: novel roles of "hemi-channels". Pflugers Arch 2009;457:1207-1226.
185. Kardami E, Dang X, Iacobas DA, Nickel BE, Jeyaraman M, Srisakuldee W, Makazan J, Tanguy S, Spray DC: The role of connexins in controlling cell growth and gene expression. Prog Biophys Mol Biol 2007;94:245-264.
186. Leithe E, Sirnes S, Omori Y, Rivedal E: Downregulation of gap junctions in cancer cells. Crit Rev Oncog 2006;12:225-256.
187. Pointis G, Fiorini C, Gilleron J, Carette D, Segretain D: Connexins as precocious markers and molecular targets for chemical and pharmacological agents in carcinogenesis.Curr Med Chem 2007;14:2288-2303.
188. Formenti SC, Demaria S: Combining radiotherapy and cancer immunotherapy: a paradigm shift. J Natl Cancer Inst 2013;105:256-265.
189. Vaiyapuri S, Jones CI, Sasikumar P, Moraes LA, Munger SJ, Wright JR, Ali MS, Sage T, Kaiser WJ, Tucker KL, Stain CJ, Bye AP, Jones S, Oviedo-Orta E, Simon AM, Mahaut-Smith MP, Gibbins JM: Gap Junctions and Connexin Hemichannels Underpin Haemostasis and Thrombosis. Circulation 2012;125:2479-2491.
190. Bermudez-Fajardo A, Yliharsila M, Evans WH, Newby AC, Oviedo-Orta E: CD4+ T lymphocyte subsets express connexin 43 and establish gap junction channel communication with macrophages in vitro. J Leukoc Biol 2007;82:608-612.
191. Mesnil M: Connexins and cancer. Biol Cell 2002;94:493-500.
192. Tsai H, Werber J, Davia MO, Edelman M, Tanaka KE, Melman A, Christ GJ, Geliebter J: Reduced connexin 43 expression in high grade, human prostatic adenocarcinoma cells. Biochem Biophys Res Commun 1996;227:64-69.
193. Chen JT, Cheng YW, Chou MC, Sen-Lin T, Lai WW, Ho WL, Lee H: The correlation between aberrant connexin 43 mRNA expression induced by promoter methylation and nodal micrometastasis in non-small cell lung cancer. Clin Cancer Res 2003;9:4200-4204.
194. Zhang W, Li HG, Fan MJ, Lv ZQ, Shen XM, He XX: Expressions of connexin 32 and 26 and their correlation to prognosis of non-small cell lung cancer. Ai Zheng 2009;28:173-176.
195. Lin Z, Zhang Z, Wang N: [Inhibition of in vivo growth of lung carcinoma cells after transfection with gap junction gene Cx43]. Zhonghua Zhong Liu Za Zhi 1997;19:253-255.
196. Mehta PP, Perez-Stable C, Nadji M, Mian M, Asotra K, Roos BA: Suppression of human prostate cancer cell growth by forced expression of connexin genes. Dev Genet 1999;24:91-110.
197. Moorby C, Patel M: Dual functions for connexins: Cx43 regulates growth independently of gap junction formation. Exp Cell Res 2001;271:238-248.
198. Koffler LS, Roshong S, Kyu Park I, Cesen-Cummings K, Thompson DC, Dwyer-Nield LD, Rice P, Mamay C, Malkinson AM, Ruch RJ: Growth inhibition in G(1) and altered expression of cyclin D1 and p27(kip-1) after forced connexin expression in lung and liver carcinoma cells. J Cell Biochem 2000;79:347-354.
199. Loncarek J, Yamasaki H, Levillain P, Milinkevitch S, Mesnil M: The expression of the tumor suppressor gene connexin 26 is not mediated by methylation in human esophageal cancer cells. Mol Carcinog 2003;36:74-81.
200. Tan LW, Bianco T, Dobrovic A: Variable promoter region CpG island methylation of the putative tumor suppressor gene Connexin 26 in breast cancer. Carcinogenesis 2002;23:231-236.
201. Simon KW, Roberts PC, Vespremi MJ, Manchen S, Schmelz EM: Regulation of beta-catenin and connexin-43 expression: targets for sphingolipids in colon cancer prevention. Mol Nutr Food Res 2009;53:332-340.
202. Zhang Y, Xu H, Wang E: [Expressions of connexin 43 and E-cadherin and their correlation in non-small cell lung cancer]. Zhongguo Fei Ai Za Zhi 2005;8:103-106.
203. Arregui CO, González A, Burdisso JE, González Wusener AE: Protein tyrosine phosphatase PTP1B in cell adhesion and migration. Cell Adh Migr 2013;7:418-23.
204. Nagasawa H, Little JB: Induction of sister chromatid exchanges by extremely low doses of alpha-particles. Cancer Res 1992;52:6394-6396.
205. Wu LJ, Randers-Pehrson G, Xu A, Waldren CA, Geard CR, Yu Z, Hei TK: Targeted cytoplasmic irradiation with alpha particles induces mutations in mammalian cells. Proc Natl Acad Sci USA 1999;96:4959-4964.
206. Shao C, Stewart V, Folkard M, Michael BD, Prise KM: Nitric oxide-mediated signaling in the bystander response of individually targeted glioma cells. Cancer Res 2003;63:8437-8342.
207. Mothersill C, Seymour CB: Cell-cell contact during gamma irradiation is not required to induce a bystander effect in normal human keratinocytes: evidence for release during irradiation of a signal controlling survival into the medium. Radiat Res 1998;149:256-262.
208. Hamada N, Maeda M, Otsuka K, Tomita M: Signaling pathways underpinning the manifestations of ionizing radiation-induced bystander effects. Curr Mol Pharmacol 2011;4:79-95.
209. Azzam EI, de Toledo SM, Little JB: Direct evidence for the participation of gap junction-mediated intercellular communication in the transmission of damage signals from alpha -particle irradiated to nonirradiated cells. Proc Natl Acad Sci USA 2001;98:473-478.
210. Persaud R, Zhou H, Baker SE, Hei TK, Hall EJ: Assessment of low linear energy transfer radiation-induced bystander mutagenesis in a three-dimensional culture model. Cancer Res 2005;65:9876-9882.
211. Seymour CB, Mothersill C: Delayed expression of lethal mutations and genomic instability in the progeny of human epithelial cells that survived in a bystander-killing environment. Radiat Oncol Investig 1997;5:106-110.
212. Nagar S, Smith LE, Morgan WF: Characterization of a novel epigenetic effect of ionizing radiation: the death-inducing effect. Cancer Res 2003;63:324-328.
213. Lewis DA, Mayhugh BM, Qin Y, Trott K, Mendonca MS: Production of delayed death and neoplastic transformation in CGL1 cells by radiation-induced bystander effects. Radiat Res 2001;156:251-258.
214. Heuskin AC, Wéra AC, Riquier H, Michiels C, Lucas S: Low-dose hypersensitivity and bystander effect are not mutually exclusive in A549 lung carcinoma cells after irradiation with charged particles. Radiat Res 2013;180:491-498.
215. Lin YF, Nagasawa H, Little JB, Kato TA, Shih HY, Xie XJ, Wilson PF Jr, Brogan JR, Kurimasa A, Chen DJ, Bedford JS, Chen BP: Differential radiosensitivity phenotypes of DNA-PKcs mutations affecting NHEJ and HRR systems following irradiation with gamma-rays or very low fluences of alpha particles. PLoS One 2014;9:e93579.
216. Zhou H, Ivanov VN, Gillespie J, Geard CR, Amundson SA, Brenner DJ, Yu Z, Lieberman HB, Hei TK: Mechanism of radiation-induced bystander effect: role of the cyclooxygenase-2 signaling pathway. Proc Natl Acad Sci USA 2005;102:14641-14646.
217. Hei TK, Zhou H, Chai Y, Ponnaiya B, Ivanov VN: Radiation induced non-targeted response: mechanism and potential clinical implications. Curr Mol Pharmacol 2011;4:96-105.
218. Bakkenist CJ, Kastan MB: DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 2003;421:499-506.
219. Matsuoka S, Ballif BA, Smogorzewska A, McDonald ER 3rd, Hurov KE, Luo J, Bakalarski CE, Zhao Z, Solimini N, Lerenthal Y, Shiloh Y, Gygi SP, Elledge SJ: ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science 2007;316:1160-1166.
220. Lee JH, Paull TT: Activation and regulation of ATM kinase activity in response to DNA double-strand breaks. Oncogene 2007;26:7741-7748.
221. Rashi-Elkeles S, Elkon R, Weizman N, Linhart C, Amariglio N, Sternberg G, Rechavi G, Barzilai A, Shamir R, Shiloh Y: Parallel induction of ATM-dependent pro- and antiapoptotic signals in response to ionizing radiation in murine lymphoid tissue. Oncogene 2006;25:1584-1592.
222. Burdak-Rothkamm S, Rothkamm K, Prise KM: ATM acts downstream of ATR in the DNA damage response signaling of bystander cells. Cancer Res 2008;68:7059-7065.
223. Ivanov VN, Zhou H, Ghandhi SA, Karasic TB, Yaghoubian B, Amundson SA, Hei TK: Radiation-induced bystander signaling pathways in human fibroblasts: a role for interleukin-33 in the signal transmission. Cell Signal 2010;22:1076-1087.
224. Ghandhi SA, Yaghoubian B, Amundson SA: Global gene expression analyses of bystander and alpha particle irradiated normal human lung fibroblasts: synchronous and differential responses. BMC Med Genomics 2008;1:63.
225. Zhang Y, Zhou J, Held KD, Redmond RW, Prise KM, Liber HL: Deficiencies of double-strand break repair factors and effects on mutagenesis in directly gamma-irradiated and medium-mediated bystander human lymphoblastoid cells. Radiat Res 2008;169:197-206.
226. Aravindan N, Aravindan S, Pandian V, Khan FH, Ramraj SK, Natt P, Natarajan M. Acquired tumor cell radiation resistance at the treatment site is mediated through radiation-orchestrated intercellular communication. Int J Radiat Oncol Biol Phys 2014;88:677-685.
227. Grivennikov SI, Karin M: Dangerous liaisons: STAT3 and NF-kappaB collaboration and crosstalk in cancer. Cytokine Growth Factor Rev 2010;21:11-19.
228. Zhou H, Ivanov VN, Lien YC, Davidson M, Hei TK: Mitochondrial function and nuclear factor-kappaB-mediated signaling in radiation-induced bystander effects. Cancer Res 2008;68:2233-2240.
229. Grivennikov S, Karin E, Terzic J, Mucida D, Yu GY, Vallabhapurapu S, Scheller J, Rose-John S, Cheroutre H, Eckmann L, Karin M: IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell 2009;15:103-113.
230. Chargari C, Clemenson C, Martins I, Perfettini JL, Deutsch E: Understanding the functions of tumor stroma in resistance to ionizing radiation: emerging targets for pharmacological modulation. Drug Resist Updat 2013;16:10-21.
231. Philips FS, Gilman A: Water and electrolyte balance in dogs intoxicated with nitrogen mustard. Am J Physiol 1948;155:295-308.
232. Farber S, Diamond LK: Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-aminopteroyl-glutamic acid. N Engl J Med 1948; 238:787-793.
233. Philips FS, Thiersch JB: Actions of 2,6-diaminopurine in mice, rats, and dogs. Proc Soc Exp Biol Med 1949;72:401-408.
234. Thiersch JB, Philips FS: Folic acid and antagonists in neoplastic disease. Am J Med Sci 1949;217:575-585.
235. Galmarini D, Galmarini CM, Galmarini FC: Cancer chemotherapy: a critical analysis of its 60 years of history. Crit Rev Oncol Hematol 2012;84:181-199.
236. Mahmud H, Föller M, Lang F: Suicidal erythrocyte death triggered by cisplatin. Toxicology 2008;249:40-44.
237. Qiu C, Coutinho P, Frank S, Franke S, Law L-Y, Martin P, Green CR, Becker DL: Targeting Connexin43 Expression Accelerates the Rate of Wound Repair. Curr Biol 2003;13:1697-1703.
238. Zhang J, O'Carroll SJ, Henare K, Ching LM, Ormonde S, Nicholson LF, Danesh-Meyer HV, Green CR: Connexin hemichannel induced vascular leak suggests a new paradigm for cancer therapy. FEBS Lett 2014;588:1365-1371.
239. Ayna G, Krysko DV, Kaczmarek A, Petrovski G, Vandenabeele P, Fésüs L: ATP release from dying autophagic cells and their phagocytosis are crucial for inflammasome activation in macrophages. PLoS One 2012;7:e40069.
240. Kolb R, Liu GH, Janowski AM, Sutterwala FS, Zhang W: Inflammasomes in cancer: a double-edged sword. Protein Cell 2014;5:12-20.
241. McKeage MJ: Comparative adverse effect profiles of platinum drugs. Drug Safe 1995;13:228-244.
242. Kim YJ, Kim J, Tian C, Lim HJ, Kim YS, Chung JH, Choung YH: Prevention of cisplatin-induced ototoxicity by the inhibition of gap junctional intercellular communication in auditory cells. Cell Mol Life Sci doi 10.1007/ s00018-014-1594-3.
243. Qadri SM, Föller M, Lang F: Inhibition of suicidal erythrocyte death by resveratrol. Life Sci 2009;85:33-38.
244. Cheng YJ, Chang MY, Chang WW, Wang WK, Liu CF, Lin ST, Lee CH: Resveratrol enhances chemosensitivity in mouse melanoma model through connexin 43 upregulation. Environ Toxicol doi: 10.1002/tox.21952.
245. Lee TM, Lin SZ, Chang NC: Both PKA and Epac pathways mediate N-acetylcysteine-induced Connexin43 preservation in rats with myocardial infarction. PLoS One 2013;8:e71878.
246. Moore K, Bryant ZJ, Ghatnekar G, Singh UP, Gourdie RG, Potts JD: A synthetic connexin 43 mimetic peptide augments corneal wound healing. Exp Eye Res 2013;115:178-188.
247. Chang WW, Lai CH, Chen MC, Liu CF, Kuan YD, Lin ST, Lee CH: Salmonella enhance chemosensitivity in tumor through connexin 43 upregulation. Int J Cancer 2013;133:1926-1935.
248. Wiita AP, Hsu GW, Lu CM, Esensten JH, Wells JA: Circulating proteolytic signatures of chemotherapy-induced cell death in humans discovered by N-terminal labeling. Proc Natl Acad Sci USA 2014;111:7594-7599.
249. Martyn KD, Kurata WE, Warn-Cramer BJ, Burt JM, TenBroek E, Lau AF: Immortalized connexin43 knockout cell lines display a subset of biological properties associated with the transformed phenotype. Cell Growth Differ 1997;8:1015-1027.
250. King TJ, Fukushima LH, Yasui Y, Lampe PD, Bertram JS: Inducible expression of the gap junction protein connexin43 decreases the neoplastic potential of HT-1080 human fibrosarcoma cells in vitro and in vivo. Mol Carcinog 2002;35:29-41.
251. Trosko JE, Ruch RJ: Gap junctions as targets for cancer chemoprevention and chemotherapy. Curr Drug Targets 2002;3:465-482.
252. Dovzhanskiy DI, Hartwig W, Lázár NG, Schmidt A, Felix K, Straub BK, Hackert T, Krysko DV, Werner J: Growth inhibition of pancreatic cancer by experimental treatment with 4-phenylbutyrate is associated with increased expression of Connexin 43. Oncol Res 2012;20:103-111.
253. Dahl G, Keane RW: Pannexin: from discovery to bedside in 11±4 years? Brain Res 2012;1487:150-159.
254. Kondratskyi A, Yassine M, Kondratska K, Skryma R, Slomianny C, Prevarskaya N: Calcium-permeable ion channels in control of autophagy and cancer. Front Physiol 2013;4:272.
255. Teleki I, Krenacs T, Szasz MA, Kulka J, Wichmann B, Leo C, Papassotiropoulos B, Riemenschnitter C, Moch H, Varga Z: The potential prognostic value of connexin 26 and 46 expression in neoadjuvant-treated breast cancer. BMC Cancer 2013;13:50.
256. Lee S, Margolin K: Cytokines in cancer immunotherapy. Cancers (Basel) 2011;3:3856-3893.
257. Okamoto T, Akiyama M, Takeda M, Akita N, Yoshida K, Hayashi T, Suzuki K: Connexin32 protects against vascular inflammation by modulating inflammatory cytokine expression by endothelial cells. Exp Cell Res 2011;317:348-355.
258. Ren JD, Fan L, Tian FZ, Fan KH, Yu BT, Jin WH, Tan YH, Cheng L: Involvement of a membrane potassium channel in heparan sulphate-induced activation of macrophages. Immunology 2014;141:345-352.
259. Chang-Chien J, Yen YC, Chien KH, Li SY, Hsu TC, Yang JJ: The connexin 30.3 of zebrafish homologue of human connexin 26 may play similar role in the inner ear. Hear Res 2014;313:55-66.
260. Mohit E, Rafati S: Chemokine-based immunotherapy: delivery systems and combination therapies. Immunotherapy 2012;4:807-840.
261. Rammensee HG, Singh-Jasuja H: HLA ligandome tumor antigen discovery for personalized vaccine approach. Expert Rev Vaccines 2013;12:1211-1217.
262. Kantoff PW, Higano CS, Shore ND, Berger ER, Small EJ, Penson DF, Redfern CH, Ferrari AC, Dreicer R, Sims RB, Xu Y, Frohlich MW, Schellhammer PF; IMPACT Study Investigators: Sipuleucel-T immunotherapy for castration-resistant prostate cancer. N Engl J Med 2010;363:411-422.
263. Huber ML, Haynes L, Parker C, Iversen P: Interdisciplinary Critique of Sipuleucel-T as Immunotherapy in Castration-Resistant Prostate Cancer. J Natl Cancer Inst 2012;104:273-279.
264. Chen G, Emens LA: Chemoimmunotherapy: reengineering tumor immunity. Cancer Immunol Immunotherapy 2013;62:203-216.
265. Hodi FS, O'Day SJ, McDermott DF, Weber RW, Sosman JA, Haanen JB, Gonzalez R, Robert C, Schadendorf D, Hassel JC, Akerley W, van den Eertwegh AJ, Lutzky J, Lorigan P, Vaubel JM, Linette GP, Hogg D, Ottensmeier CH, Lebbé C, Peschel C, Quirt I, Clark JI, Wolchok JD, Weber JS, Tian J, Yellin MJ, Nichol GM, Hoos A, Urba WJ: Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med 2010;363:711-723.
266. Devaud C, John LB, Westwood JA, Darcy PK, Kershaw MH: Immune modulation of the tumor microenvironment for enhancing cancer immunotherapy. Oncoimmunology 2013;2:e25961.
267. McAllister F, Bailey JM, Alsina J, Nirschl CJ, Sharma R, Fan H, Rattigan Y, Roeser JC, Lankapalli RH, Zhang H, Jaffee EM, Drake CG, Housseau F, Maitra A, Kolls JK, Sears CL, Pardoll DM, Leach SD: Oncogenic Kras Activates a Hematopoietic-to-Epithelial IL-17 Signaling Axis in Preinvasive Pancreatic Neoplasia. Cancer Cell 2014;25:621-637.
268. Kryczek I, Lin Y, Nagarsheth N, Peng D, Zhao L, Zhao E, Vatan L, Szeliga W, Dou Y, Owens S, Zgodzinski W, Majewski M, Wallner G, Fang J, Huang E, Zou W: IL-2+CD4+ T Cells Promote Colorectal Cancer Stemness via STAT3 Transcription Factor Activation and Induction of the Methyltransferase DOT1L. Immunity 2014;40:772-784.
269. Ferarelli LK: Unhelpful T-cells & inflammation. Sci Signal 2014;7:ec141.
270. Ferrarelli LK: Refining the war on cancer. Sci Signal 2014;7:eg2.
271. Levin M: Endogenous bioelectrical networks store non-genetic patterning information during development and regeneration. J Physiol 2014;592:2295-2305.
272. Shi R, Borgens RB: Three-dimensional gradients of voltage during development of the nervous system as invisible coordinates for the establishment of embryonic pattern. Dev Dyn 1995;202:101-114.
273. McCaig CD, Song B, Rajnicek AM: Electrical dimensions in cell science. J Cell Sci 2009;122:4267-4276.